| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ABBVIE INC | 1,580,000 | 85,968,000 | 21.23% | ||
| 2 | ARIAD PHARMACEUTICALS INC | 12,850,000 | 75,044,000 | 18.53% | ||
| 3 | MEDICINES CO | 1,567,000 | 59,483,000 | 14.69% | ||
| 4 | QUEST DIAGNOSTICS INC | 575,000 | 35,345,000 | 8.73% | ||
| 5 | AEGERION PHARMACEUTICALS INC | 2,555,000 | 34,748,000 | 8.58% | ||
| 6 | INTRA CELLULAR THERAPIES INC COM | 640,000 | 25,626,000 | 6.33% | ||
| 7 | MERCK & CO INC | 400,000 | 19,756,000 | 4.88% | ||
| 8 | PACIRA BIOSCIENCES INC | 380,000 | 15,618,000 | 3.86% | ||
| 9 | AMGEN INC | 90,000 | 12,449,000 | 3.07% | ||
| 10 | Esperion Therapeutics Inc | 448,000 | 10,568,000 | 2.61% | ||
| 11 | Apricus Biosciences, Inc. | 6,524,505 | 9,526,000 | 2.35% | ||
| 12 | REPROS THERAPEUTICS INC | 1,132,367 | 8,413,000 | 2.08% | ||
| 13 | VIVUS INC | 2,573,943 | 4,221,000 | 1.04% | ||
| 14 | KINDRED BIOSCIENCES INC | 689,091 | 3,583,000 | 0.88% | ||
| 15 | AVEO PHARMACEUTICALS INC | 2,313,759 | 2,800,000 | 0.69% | ||
| 16 | ANI PHARMACEUTICALS INC COM | 31,000 | 1,225,000 | 0.30% | ||
| 17 | Catalyst Biosciences | 90,000 | 419,000 | 0.10% | ||
| 18 | ELEVEN BIOTHERAPEUTICS INC | 41,200 | 99,000 | 0.02% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-15-041780, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
